Unlock your academic potential and expand your network by joining us!
Carmen Jerónimo obtained her BSc in Biology (1994), MSc in Oncology (1998), PhD in Biomedical Sciences (2001), and Habilitation in Pathology and Molecular Genetics (2011) at the University of Porto. She performed her PhD project at Johns Hopkins University (JHU), USA under the GABBA Program, working on prostate cancer genetic and epigenetic alterations. From 2002 until 2007, she was a Post-Doctoral Fellow and Invited Researcher at IPO Porto, in collaboration with JHU, working on the non-invasive detection of neoplastic cells by DNA-based technology. In 2008, she established her independent group at IPO Porto, working on Cancer Biology and Epigenetics (FCT-2008 Science Program). Carmen Jerónimo is currently the Director of the Research Group Leader of the Cancer Biology and Epigenetics Group and the Scientific Coordinator of the Biobank at the Portuguese Oncology Institute of Porto (IPO Porto), and Invited Full Professor in the Department of Pathology and Molecular Genetics and the Director of the Master Course in Oncology at the Biomedical Sciences Institute-University of Porto (ICBAS-UP), teaching Pathology and Cancer Genetics and Epigenetics, both undergraduate and postgraduate Courses. She has authored/co-authored more than 250 international scientific publications, including 1 book, (H-index 54; Scopus 10/2023): https://www.scopus.com/authid/detail.uri?authorId=57197057169, and several original articles in first quartile (Q1) journals.
Carmen Jerónimo obtained her BSc in Biology (1994), MSc in Oncology (1998), PhD in Biomedical Sciences (2001), and Habilitation in Pathology and Molecular Genetics (2011) at the University of Porto. She performed her PhD project at Johns Hopkins University (JHU), USA under the GABBA Program, working on prostate cancer genetic and epigenetic alterations. From 2002 until 2007, she was a Post-Doctoral Fellow and Invited Researcher at IPO Porto, in collaboration with JHU, working on the non-invasive detection of neoplastic cells by DNA-based technology. In 2008, she established her independent group at IPO Porto, working on Cancer Biology and Epigenetics (FCT-2008 Science Program). Carmen Jerónimo is currently the Director of the Research Group Leader of the Cancer Biology and Epigenetics Group and the Scientific Coordinator of the Biobank at the Portuguese Oncology Institute of Porto (IPO Porto), and Invited Full Professor in the Department of Pathology and Molecular Genetics and the Director of the Master Course in Oncology at the Biomedical Sciences Institute-University of Porto (ICBAS-UP), teaching Pathology and Cancer Genetics and Epigenetics, both undergraduate and postgraduate Courses. She has authored/co-authored more than 250 international scientific publications, including 1 book, (H-index 54; Scopus 10/2023): https://www.scopus.com/authid/detail.uri?authorId=57197057169, and several original articles in first quartile (Q1) journals.
You can be the first follower.
